Effect of reclassification of cannabis on hospital admissions for cannabis psychosis: A time series analysis

International Journal of Drug Policy

Volumn 25, Issue 1, 2014, Pages 151-156

  Hamilton, Ian ^a   Lloyd, Charlie ^a   Hewitt, Catherine ^a   Godfrey, Christine ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Cannabis; Interrupted time series; Psychosis; Reclassification

Indexed keywords

CANNABIS;

ARTICLE; CANNABIS PSYCHOSIS; CANNABIS USE; DRUG CONTROL; HOSPITAL ADMISSION; HUMAN; MENTAL HOSPITAL; PRIORITY JOURNAL; PSYCHOSIS; TIME SERIES ANALYSIS; TREND STUDY; UNITED KINGDOM;

CANNABIS; INTERRUPTED TIME SERIES; PSYCHOSIS; RECLASSIFICATION;

CANNABIS; GREAT BRITAIN; HEALTH POLICY; HOSPITALIZATION; HUMANS; MODELS, STATISTICAL; PSYCHOSES, SUBSTANCE-INDUCED;

EID: 84893015481     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2013.05.016     Document Type: Article

References (30)

1. Advisory Council on the Misuse of Drugs Further consideration of the classification of cannabis under the Misuse of Drugs Act 1971 2005, Home Office, London.
2. Advisory Council on the Misuse of Drugs Cannabis: Classification and public health 2008, Home Office, London.
3. Arseneault L., Cannon M., Witton J., Murray R.M. Causal association between cannabis and psychosis: Examination of the evidence. British Journal of Psychiatry 2004, 184:110-117.
4. Association of Chief Police Officers ACPO guidance on cannabis possession for personal use 2009, ACPO, London.
5. Baldacchino A., Hughes Z., Kehoe M., et al. Cannabis Psychosis: Examining the evidence for a Distinct Psychopathology in a systematic and narrative review. The American Journal on addictions 2012, 21:S88-S98.
6. Bennett A. Cannabis: A harm reduction perspective. A cannabis reader: Global issues and local experiences 2008, EMCDDA, Lisbon. S.R. Sznitman, B. Olsson, R. Room (Eds.).
7. Biglan A., Ary D., Wagenaar A.C. The value of interrupted time-series experiments for community intervention research. Prevention Science 2000, 1(1):31-49.
8. Cascini F., Aiello C., Di Tanna G. Increasing delta-9-tetrahydrocannabinol (δ-9-THC) content in herbal cannabis over time: Systematic review and meta-analysis. Current Drug Abuse Reviews 2012, 5:32-40.
9. Coggans N., Dalgarno P., Johnson L., Shewan D. Long-term Heavy Cannabis Use: Implications for health education. Drugs: Education, Prevention and Policy 2004, 11(4):299-313.
10. England E. How interrupted time series analysis can evaluate guideline implementation. The Pharmaceutical Journal 2005, 275:344-347.
11. Frisher M., Crome I., Martino O., Croft P. Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005. Schizophrenia Research 2009, 113:123-128.
12. Gage S.H., Zammit S., Hickman M. Stronger evidence is needed before accepting that cannabis plays an important role in the aetiology of schizophrenia in the population. F1000 Medicine Reports 2013, 5:2.
13. Hartmann D.P., Gottman J.M., Jones R.R., et al. Interrupted Time series and its application to behavioral data. Journal of Applied Behavior Analysis 1980, 13(4):543-559.
14. Health and Social Care Information Centre In-patients formally detained in hospitals under the Mental Health Act, 1983 - and patients subject to supervised community treatment, annual figures, England 2010/2011 2011, HSCIC, London.
15. Hickman M., Vickerman P., Macleod J., et al. Cannabis and schizophrenia: Model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales. Addiction 2007, 102:597-606.
16. Lloyd C. The cannabis classification debate in the UK: Full of sound and fury, signifying nothing. Paper presented at the international society of drug policy conference 2008.
17. Lloyd C. UK cannabis classification: A flawed debate. The Lancet 2008, 371(January):300-301.
18. Lloyd C., McKeganey N. Drugs research: An overview of evidence and questions for policy 2010, Joseph Rowntree Foundation, York.
19. McBride A.J. Cannabis use in a drug and alcohol clinic population. Drug and Alcohol Dependence 1995, 39(1):29-32.
20. McLaren J., Switft W., Dillon P., Allsop S. Cannabis potency and contamination: A review of the literature. Addiction 2008, 103:1100-1109.
21. May T., Duffy M., Warburton H., Hough M. Policing cannabis as a Class C drug 2007, Joseph Rowntree Foundation, York.
22. 9 THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008. Forensic Sciences 2010, 55(5):1209-1217.
23. Ramsey C.R. Interrupted Time Series Designs in Health Technology Assessment: Lessons from two systematic reviews of behavior change strategies. International Journal of Technology Assessment in Health Care 2003, 19(4):613-623.
24. Shadish W.R., Cook T.D., Campbell D.T. Experimental and quasiexperimental designs for generalized causal inference 2002, Houghton Mifflin, Boston.
25. Turkingdon D., Weiden P. Back to life, back to normality. Cognitive therapy, recovery and psychosis 2009, Cambridge University Press, Cambridge.
26. UK Drug Policy Commission A fresh approach to drugs. The final report of the UK drug policy commission 2012, Available at: http://www.ukdpc.org.uk/wp-content/uploads/a-fresh-approach-to-drugs-the-final-report-of-the-uk-drug-policy-commission.pdf (Accessed 15.10.12).
27. Wagner A.K., Soumerai S.B., Zhang F., Ross-Degnan D. Segmented analysis of interrupted time series studies in medication use research. Journal of Clinical Pharmacy and Therapeutics 2002, 27:299-309.
28. Warburton H., May T., Hough M. Looking the other way. British Journal of Criminology 2005, 45:113-128.
29. Weissenborn R., Nutt C. Popular intoxicants: What lessons can be learned from the last 40 years of alcohol and cannabis regulation?. Journal of Psychopharmacology 2012, 26(2):213-220.
30. World Health Organisation International classification of disease 2010, http://apps.who.int/classifications/apps/icd/icd10online/ (Accessed 07.05.13).